Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 2/20 | 0.55 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | NT5E | P21589 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL1326320 | 1.00 | CA5A (0.55) | CA5ACA5BTSHRCA2TDP1 | |
| Phosphoric Acid SCHEMBL5343874 | 1.00 | CA5A (0.55) | CA5ACA5BTSHRCA2TDP1 | |
| Phosphoric Acid SCHEMBL28164160 | 0.96 | CA5A (0.50) | CA5ACA5BTSHRCA2TDP1 | |
| Phosphoric Acid SCHEMBL28270321 | 0.96 | CA5A (0.50) | CA5ACA5BTSHRCA2TDP1 | |
| Phosphoric Acid SCHEMBL27635906 | 0.96 | CA5A (0.50) | CA5ACA5BTSHRCA2TDP1 | |
| Phosphoric Acid SCHEMBL6231084 | 0.96 | CA5A (0.50) | CA5ACA5BTSHRCA2TDP1 | |
| Phosphoric Acid SCHEMBL5340898 | 0.96 | CA5A (0.50) | CA5ACA5BTSHRCA2TDP1 | |
| Phosphoric Acid SCHEMBL29268866 | 0.96 | CA5A (0.50) | CA5ACA5BTSHRCA2TDP1 | |
| Phosphoric Acid SCHEMBL20914382 | 0.96 | CA5A (0.50) | CA5ACA5BTSHRCA2TDP1 | |
| Phosphoric Acid SCHEMBL28268676 | 0.96 | CA5A (0.50) | CA5ACA5BTSHRCA2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023218472-A1 | AN AQUEOUS OPHTHALMIC SOLUTION OF NSAIDS AND FLUOROQUINOLONE ANTIBIOTIC AND PROCESS OF PREPARATION THEREOF | AKUMS DRUGS & PHARMACEUTICALS LIMITED (IN) | 2023-11-16 | — | — | WO | claimed |
| WO-2024142116-A1 | STABLE PHARMACEUTICAL COMPOSITION FOR OTITIS EXTERNA | SENTISS PHARMA PRIVATE LIMITED (IN) | 2024-07-04 | — | — | WO | disclosed |
| US-11844832-B2 | Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production | NAJIT TECHNOLOGIES, INC. (US) | 2023-12-19 | — | — | US | disclosed |
| WO-2023218472-A1 | AN AQUEOUS OPHTHALMIC SOLUTION OF NSAIDS AND FLUOROQUINOLONE ANTIBIOTIC AND PROCESS OF PREPARATION THEREOF | AKUMS DRUGS & PHARMACEUTICALS LIMITED (IN) | 2023-11-16 | — | — | WO | disclosed |
| CN-115337407-A | Treatment of AMD using AAVSFLT-1 | 阿瓦兰克澳大利亚私人有限公司 | 2022-11-15 | — | — | CN | disclosed |
| US-20210196812-A1 | INORGANIC POLYATOMIC OXYANIONS FOR PROTECTING AGAINST ANTIGENIC DAMAGE DURING PATHOGEN INACTIVATION FOR VACCINE PRODUCTION | Najít Technologies, Inc. | 2021-07-01 | — | — | US | disclosed |
| CN-111533900-A | Plastic antibacterial agent and antibacterial plastic | 朱金娥 | 2020-08-14 | — | — | CN | disclosed |
| CN-111454560-A | Antibacterial polycarbonate plastic and preparation method thereof | 朱金娥 | 2020-07-28 | — | — | CN | disclosed |
| CN-110475543-A | Eye medicinal extended release preparation and application thereof | MATI THERAPEUTICS INC | 2019-11-19 | — | — | CN | disclosed |
| EP-3504227-A1 | IDENTIFICATION OF MUTATIONS IN CHANNELOPSIN VARIANTS HAVING IMPROVED LIGHT SENSITIVITY AND METHODS OF USE THEREOF | Wayne State University (US) | 2019-07-03 | — | — | EP | disclosed |
| WO-2018044912-A1 | IDENTIFICATION OF MUTATIONS IN CHANNELOPSIN VARIANTS HAVING IMPROVED LIGHT SENSITIVITY AND METHODS OF USE THEREOF | WAYNE STATE UNIVERSITY (US) | 2018-03-08 | — | — | WO | disclosed |
| US-20130267591-A1 | NOVEL OPHTHALMIC COMPOSITIONS | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2013-10-10 | — | — | US | disclosed |
| EP-2566453-A1 | NOVEL OPHTHALMIC COMPOSITIONS | Sun Pharma Advanced Research Company Ltd (IN) | 2013-03-13 | — | — | EP | disclosed |
| WO-2011138801-A1 | NOVEL OPHTHALMIC COMPOSITIONS | SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) | 2011-11-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210196812-A1 | INORGANIC POLYATOMIC OXYANIONS FOR PROTECTING AGAINST ANTIGENIC DAMAGE DURING PATHOGEN INACTIVATION FOR VACCINE PRODUCTION | OGG1, EIF2AK2, AS3MT | CA5A 886/4885CA5B 656/4885TSHR 3359/4885 |
| US-11844832-B2 | Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production | OGG1, EIF2AK2, AS3MT | CA5A 886/4885CA5B 656/4885TSHR 3359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.